About Ecso Global Private Limited
Data last updated: 05 January 2026
Ecso Global Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 15 June 2016, the company has been in operation for over 10 years.
Registered with ROC Delhi under CIN U51909DL2016PTC301380.
Capital: an authorised share capital of ₹14.1 Lakh and a paid-up capital of ₹3.32 Lakh. It is led by directors Prateek Rawat and Agam Khare.
Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: 4Th Floor Statesman House Barakhamba Road Connaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2022, the company reported a revenue of ₹361.52 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 410 employees as per the latest available data.
The company is associated with 1 brand - Absolute. As per MCA filings, the company has open charges of ₹114.25 Cr and satisfied charges of ₹15 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website absolutefoods.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address4Th Floor Statesman House Barakhamba Road Connaught Place, New Delhi, Delhi, India – 110001
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Ecso Global Private Limited
Ecso Global Private Limited operates one associated brand: Absolute. These brands represent Ecso Global Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Biological technologies are developed for agriculture, healthcare, and materials science. | absolute.ag |
Competitors & Alternatives of Ecso Global Private Limited
Brands and companies operating in the same space as Ecso Global Private Limited include Titan Biotech, IPL Biologicals, Univia and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Titan Biotech
|
Biological products are manufactured and exported for various industries. | Delhi, India, India | 1992 |
IPL Biologicals
|
Plant nutrition and protection products are manufactured and supplied. | Gurugram, India, India | 1994 |
Univia
|
Agri-input retailers are connected to farmers via a phygital network. | Ahmedabad, India, India | 2020 |
Sri Biotech Laboratories
|
Crop improvement research and nutrient manufacturing are conducted. | Hyderabad, India, India | 1994 |
Capsber
|
Diversified crop biological solutions are provided for farmers. | Bengaluru, India, India | 2022 |
Lab2Land
|
Agrochemicals, fertilizers, and crop nutrition solutions are researched and developed. | Hyderabad, India, India | 2020 |
Criyagen
|
Develops innovative technologies for organic and bio-active farm inputs. | Bengaluru, India, India | 2008 |
Shivashakthi BioTechnologies
|
Development and commercial production of plantlets and farm inputs | Hyderabad, India, India | 2001 |
Varsha Bioscience and Technology
|
Bio-pesticides, bio-fertilizers, and plant growth promoters are manufactured. | Hyderabad, India, India | 2003 |
Business Activity of Ecso Global Private Limited
Ecso Global Private Limited is engaged in principal business activities including agriculture, forestry, fishing and trade, with detailed activities including production of crops and animals, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A1 | Production of crops and animals | ********* |
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Ecso Global Private Limited
Ecso Global Private Limited is audited by S.R.BATLIBOI & CO. LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.R.BATLIBOI & CO. LLP | blur-value | blur-value | blur-value |
Board of Directors of Ecso Global Private Limited
Ecso Global Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Prateek Rawat
Also directs:
Inera Cropscience Private Limited, Upaj Ai Solutions Private Limited, Grow Well Organic And Eco Products Private Limited and 3 more
|
Director | 04 Feb 2019 | 7 Years 5 Months | Current |
|
Agam Khare
Also directs:
Inera Cropscience Private Limited, Upaj Ai Solutions Private Limited, Grow Well Organic And Eco Products Private Limited and 3 more
|
Director | 15 Jun 2016 | 10 Years 0 Months | Current |
Financials of Ecso Global Private Limited FY 2022 filings available
Ecso Global Private Limited reported revenue of ₹361.52 Cr (up 1170% YoY) for FY 2022. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Ecso Global Private Limited
As of FY 2022, Ecso Global Private Limited's shareholding pattern shows 84.88% by promoters, 3.05% by domestic institutional investors (DII), 4.87% by foreign institutional investors (FII), 7.21% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Ecso Global Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2024 | Others | ₹7.5 Cr | Open |
| 30 Jun 2023 | Citi Bank N.A. | ₹17.5 Cr | Open |
| 29 Mar 2023 | Others | ₹17.5 Cr | Open |
| 09 Mar 2023 | The Hongkong and Shanghai Banking Corporation Limited | ₹71.75 Cr | Open |
| 25 Oct 2024 | Others | ₹15 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Ecso Global Private Limited
Ecso Global Private Limited has a workforce of 410 employees as of Apr 09, 2024.
Employee Count & EPFO Data of Ecso Global Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Ecso Global Private Limited
GSTIN & GST Filing Data of Ecso Global Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Ecso Global Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Ecso Global Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Ecso Global Private Limited
MSME Payment Delays by Ecso Global Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Ecso Global Private Limited
Subsidiaries & Group Companies of Ecso Global Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ecso Global Private Limited with ownership details.
MCA Filings & Documents of Ecso Global Private Limited
MCA Filings & Documents of Ecso Global Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Ecso Global Private Limited
Frequently Asked Questions about Ecso Global Private Limited
Ecso Global Private Limited is an active private limited company in the life sciences sector based in New Delhi, Delhi, India. It was incorporated on 15 June 2016 (10+ years old) and is registered under CIN U51909DL2016PTC301380. The company has 410 employees.
Ecso Global Private Limited reported revenue of ₹361.52 Cr for FY 2022 (up 1170.00% YoY).
The current directors of Ecso Global Private Limited are:
The primary industry of Ecso Global Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes, Ecso Global Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Ecso Global Private Limited can be reached at the registered office: 4Th Floor Statesman House Barakhamba Road Connaught Place, New Delhi, Delhi, India – 110001, or through the website absolutefoods.in.